Regeneron-Pharmaceuticals

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-02
Total Holdings
6
Total Value
1234240208
Accession Number
0001104659-25-044118
Form Type
13F-HR
Manager Name
Regeneron-Pharmaceuticals
Data Enrichment
100% identified
6 identified0 unidentified

Holdings

6 positions
Manager:
Search and click to pin securities to the top
ALNYLAM PHARMACEUTICALS, INC.
Shares:4.4M
Value:$1.2B
Intellia Therapeutics, Inc.
Shares:3.7M
Value:$26.3M
2seventy bio, Inc.
Shares:1.3M
Value:$6.2M
Adverum Biotechnologies, Inc.
Shares:180.9K
Value:$790.6K
Adicet Bio, Inc.
Shares:968.2K
Value:$731.0K
bluebird bio, Inc.
Shares:21.0K
Value:$102.5K